Company Active LTD

Company profile

Cipherx Technologies Ltd

CipherX | A New Era of Tattooing

Be your own tattoo artists and create custom tattoos with our easy-to-use online design tool. With our new microneedle technology, design and export a unique patch to apply safely at home.

CRN
13607960
Founded
2021
Age
4

Overview

Legal name
CIPHERX TECHNOLOGIES LTD
Region
Unknown
Registered address
SCALE SPACE BUILDING
WOOD LANE 58
LONDON
ENGLAND
W12 7RZ
Insolvency history
No

Latest accounts

Financial period: 1 Oct 2024 to 30 Sep 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Jun
2027

Accounts due

Accounts Due

Next accounts due date

12 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

29 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

06 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNDc1ODMxOWFkaXF6a2N4

Published 06 Sep 2024 09:21

07 Sep
2021

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2024
Funded years
2024, 2026
Age at first award
2 years

Projects

2026 Collaborative R&D Lead participant

CHROMASKIN: Minimally-Invasive Interstitial Fluid Sensing Materials for Semi-Permanent Dermal Readouts

1 May 2026 to 31 Jan 2027

Awarded
£99,780
Total cost £142,543

CHROMASKIN is an innovative dermal biosensing technology that enables people to monitor key health markers using a small, painless microneedle patch. When placed on the skin, the microneedle penetrate the skin dissolve and deposit tiny colour-changing particles into the dermis. These particles interact with the body's interstitial fluid and change colour ...

2024 Collaborative R&D Lead participant

FREEDOM: Female REproductive Empowerment and DOse Management

1 Oct 2024 to 31 Mar 2026

Awarded
£251,962
Total cost £359,946

The **FREEDOM-Patch** (**F**emale **RE**productive **E**mpowerment and **DO**se **M**anagement Patch) project is a collaborative effort between CipherX Technologies and the Stevens Group at the University of Oxford. This 18-month feasibility project aims to develop a next-generation female contraceptive device utilising advanced microneedle-array patch te...

2024 Collaborative R&D Lead participant

Development of a novel microneedle based technology with integrated delivery confirmation to enhance self-administration reliability of needle-free vaccines.

1 Aug 2024 to 30 Apr 2025

Awarded
£50,834
Total cost £72,620

The healthcare and vaccine delivery sectors, while essential, face significant challenges in ensuring global vaccine accessibility and minimising wastage. These challenges are compounded by the reliance on cold chain logistics and the necessity for skilled healthcare personnel for vaccine administration. In response, CipherX and Nemaura have embarked on a...

Product types

Collaborative R&D